| Literature DB >> 29056894 |
Inga Schneider1, Theresa Greupner1, Andreas Hahn1.
Abstract
The aim of the present study was to compare the magnesium bioavailability from four mineral waters with different types of mineralization (e.g. SO42-, HCO3-, calcium) with the magnesium bioavailability from bread and from a magnesium supplement. A single-center, randomized, controlled trial with a crossover design with 22 healthy men and women was conducted at the Institute of Food Science and Human Nutrition, Leibniz University Hannover, Germany. The participants consumed the six test products providing 100 mg of magnesium each on six examination days with a one-week washout phase in between. The primary outcome variables were the 24 h urinary magnesium excretion, the 24 h urinary magnesium/creatinine ratio, and the area under the curve of serum magnesium levels for 10 h (AUC0-10h). No significant differences among groups were observed for either 24 h urinary magnesium excretion or 24 h urinary magnesium/creatinine ratio. Likewise, statistical group comparisons of AUC0-10h for serum magnesium levels revealed no significant differences among the treatment groups. Accordingly, given equivalent magnesium availability from all test products, neither SO42- content nor the content of HCO3- or of calcium influenced the bioavailability of magnesium. Thus, mineral water with higher concentrations of magnesium constitutes a calorie-free magnesium source that contributes to optimal magnesium supply.Entities:
Keywords: Mineral water; bioavailability; general nutrition; magnesium; mineralization
Year: 2017 PMID: 29056894 PMCID: PMC5642192 DOI: 10.1080/16546628.2017.1384686
Source DB: PubMed Journal: Food Nutr Res ISSN: 1654-661X Impact factor: 3.894
Mineral composition of the six test products (MW 1: mineral water 1; MW 2: mineral water 2; MW 3: mineral water 3; MW 4: mineral water 4; Suppl.: magnesium supplement) .
| Mineral value | MW 1 | MW 2 | MW 3 | MW 4 | Bread a | Suppl.b |
|---|---|---|---|---|---|---|
| Mg2+ | 241 mg/l | 108 mg/l | 124 mg/l | 137 mg/l | 531 mg/kg | 110 mg/pill |
| Ca2+ | 168 mg/l | 348 mg/l | 528 mg/l | 290 mg/l | n.a. | - |
| Na+ | 261 mg/l | 118 mg/l | 28.8 mg/l | 100 mg/l | n.a. | - |
| Cl− | 14 mg/l | 40 mg/l | 28.9 mg/l | 181 mg/l | n.a. | - |
| SO42- | 17 mg/l | 38 mg/l | 1463 mg/l | 8.8 mg/l | n.a. | - |
| HCO3− | 2451 mg/l | 1816 mg/l | 403 mg/l | 1519 mg/l | n.a. | - |
n.a.: not analyzed; a whole rye; b magnesium carbonate (MgCO3)
Twenty-four hours of urinary magnesium excretion, 24 h urinary magnesium/creatinine ratio, and area under the curve (AUC0-10h) for serum magnesium levels for 10 h (mean ± SD).
| 24 h urinary Mg excretion [mmol] | 24 h urinary Mg/creatinine ratio [mmol] | AUC0-10h serum Mg | ||||
|---|---|---|---|---|---|---|
| MW 1 | 4.41 ± 1.50 | n = 22 | 0.55 ± 0.79 | n = 18 | 0.80 ± 0.35 | n = 22 |
| MW 2 | 4.47 ± 1.17 | n = 20 | 0.43 ± 0.15 | n = 18 | 0.89 ± 0.40 | n = 21 |
| MW 3 | 4.41 ± 1.58 | n = 22 | 0.40 ± 0.08 | n = 18 | 0.78 ± 0.37 | n = 22 |
| MW 4 | 4.68 ± 1.44 | n = 21 | 0.71 ± 1.36 | n = 18 | 0.99 ± 0.39 | n = 21 |
| Bread | 4.12 ± 1.74 | n = 22 | 0.34 ± 0.07 | n = 18 | 0.81 ± 0.31 | n = 22 |
| Suppl. | 4.21 ± 1.53 | n = 21 | 0.35 ± 0.07 | n = 18 | 0.82 ± 0.32 | n = 22 |
| p | 0.1942 | 0.382a | 0.401a | |||
a sphericity given
b Greenhouse–Geisser correction
Figure 1.Mean ± SD urinary magnesium excretion (A; MW 1: n = 22, MW 2: n = 20, MW 3: n = 22, MW 4: n = 21, Bread: n = 21, Suppl.: n = 22) and mean ± SD serum magnesium concentrations corrected to baseline (B; MW 1: n = 22, MW 2: n = 21, MW 3: n = 22, MW 4: n = 21, Bread: n = 22, Suppl.: n = 22) after consumption of the test products.